INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M407. A total of 32 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $166,000 | -31.1% | 736,572 | +53.0% | 0.00% | – |
Q3 2019 | $241,000 | -25.6% | 481,354 | +10.0% | 0.00% | – |
Q2 2019 | $324,000 | -45.2% | 437,582 | +14.8% | 0.00% | -100.0% |
Q1 2019 | $591,000 | +8.0% | 381,082 | +5.2% | 0.00% | 0.0% |
Q4 2018 | $547,000 | +14.4% | 362,282 | +53.1% | 0.00% | – |
Q3 2018 | $478,000 | +126.5% | 236,672 | +90.3% | 0.00% | – |
Q2 2018 | $211,000 | – | 124,372 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CVI Holdings, LLC | 156,655 | $266,000 | 0.33% |
Stonepine Capital Management, LLC | 77,900 | $132,000 | 0.08% |
Anson Funds Management LP | 54,450 | $93,000 | 0.06% |
SABBY MANAGEMENT, LLC | 169,661 | $288,000 | 0.04% |
IMS Capital Management | 24,916 | $42,000 | 0.03% |
Paulson Wealth Management Inc. | 11,250 | $4,000 | 0.00% |
WEDBUSH SECURITIES INC | 16,250 | $28,000 | 0.00% |
PEDDOCK CAPITAL ADVISORS, LLC | 1 | $0 | 0.00% |
UBS Group AG | 1,813 | $3,000 | 0.00% |
MARINO, STRAM & ASSOCIATES LLC | 2 | $0 | 0.00% |